NOVO.B.DK

236.4

-0.27%↓

GMAB.DK

1,662

+1.19%↑

HLUNB.DK

37.62

+0.64%↑

ZEAL.DK

280.3

-2.67%↓

AMBUB.DK

68.15

+0.74%↑

NOVO.B.DK

236.4

-0.27%↓

GMAB.DK

1,662

+1.19%↑

HLUNB.DK

37.62

+0.64%↑

ZEAL.DK

280.3

-2.67%↓

AMBUB.DK

68.15

+0.74%↑

NOVO.B.DK

236.4

-0.27%↓

GMAB.DK

1,662

+1.19%↑

HLUNB.DK

37.62

+0.64%↑

ZEAL.DK

280.3

-2.67%↓

AMBUB.DK

68.15

+0.74%↑

NOVO.B.DK

236.4

-0.27%↓

GMAB.DK

1,662

+1.19%↑

HLUNB.DK

37.62

+0.64%↑

ZEAL.DK

280.3

-2.67%↓

AMBUB.DK

68.15

+0.74%↑

NOVO.B.DK

236.4

-0.27%↓

GMAB.DK

1,662

+1.19%↑

HLUNB.DK

37.62

+0.64%↑

ZEAL.DK

280.3

-2.67%↓

AMBUB.DK

68.15

+0.74%↑

Search

Coloplast A-S (Class B)

Suletud

424.5 -0.47

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

414.4

Max

431.7

Põhinäitajad

By Trading Economics

Sissetulek

522M

1.4B

Müük

83M

7B

P/E

Sektori keskmine

25.56

57.833

Aktsiakasum

6.32

Dividenditootlus

5.07

Kasumimarginaal

19.835

Töötajad

16,983

EBITDA

309M

2.3B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

5.07%

2.47%

Järgmine tulemuste avaldamine

12. mai 2026

Järgmine dividendimakse kuupäev

20. mai 2026

Järgmine aktsia dividendi kuupäev (ex-date)

18. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-17B

102B

Eelmine avamishind

424.97

Eelmine sulgemishind

424.5

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. märts 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

22. märts 2026, 23:50 UTC

Market Talk

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22. märts 2026, 23:49 UTC

Market Talk
Uudisväärsed sündmused

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22. märts 2026, 23:49 UTC

Market Talk
Uudisväärsed sündmused

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22. märts 2026, 23:49 UTC

Market Talk
Uudisväärsed sündmused

Global Forex and Fixed Income Roundup: Market Talk

22. märts 2026, 23:41 UTC

Market Talk
Uudisväärsed sündmused

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22. märts 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22. märts 2026, 22:56 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22. märts 2026, 22:56 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22. märts 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Participated in Aurum Resources Equity Raising

22. märts 2026, 22:54 UTC

Omandamised, ülevõtmised, äriostud

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22. märts 2026, 22:22 UTC

Market Talk
Uudisväärsed sündmused

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22. märts 2026, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22. märts 2026, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22. märts 2026, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22. märts 2026, 22:06 UTC

Omandamised, ülevõtmised, äriostud

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22. märts 2026, 21:53 UTC

Tulu

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22. märts 2026, 21:53 UTC

Tulu

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22. märts 2026, 21:53 UTC

Tulu

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22. märts 2026, 21:53 UTC

Tulu

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22. märts 2026, 21:31 UTC

Tulu

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22. märts 2026, 21:25 UTC

Market Talk
Uudisväärsed sündmused

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22. märts 2026, 21:22 UTC

Omandamised, ülevõtmised, äriostud

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22. märts 2026, 21:21 UTC

Omandamised, ülevõtmised, äriostud

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22. märts 2026, 21:21 UTC

Market Talk

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22. märts 2026, 21:21 UTC

Omandamised, ülevõtmised, äriostud

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat